Petros Giovanis - Publications

Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.

Journal: Cancers

Published: September 14, 2023

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.

Journal: EClinicalMedicine

Published: March 07, 2023

Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.

Journal: The oncologist

Published: September 05, 2021

A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients.

Journal: Diagnostics (Basel, Switzerland)

Published: September 08, 2020

Capecitabine in advanced hepatocellular carcinoma: A multicenter experience.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 13, 2019

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).

Journal: The oncologist

Published: October 18, 2018

Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial.

Journal: Pharmacological research

Published: January 30, 2018

Circulating endothelial cells and risk of progression in patients with hepatocellular cancer receiving sorafenib.

Journal: Hepatic oncology

Published: April 01, 2017

Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy

Journal: Recenti progressi in medicina

Published: May 22, 2015